Molecular Diagnostics Market Research Report - Global Forecast till 2030

Molecular Diagnostics Market

As per Global Market, the global market is anticipated to witness growth owing to the factors such as technological advancements in molecular diagnostics as well as the increasing prevalence of hospital-acquired infections. However, the market will face challenges and restraints due to the stringency of molecular diagnostics regulations and the restrictive nature of the regulatory framework during the forecast period.

The Molecular Diagnostics Market size is projected to reach USD 29.3 billion by 2030 at 5.7% CAGR during the forecast period 2022-2030. 

The detection of numerous diseases in the market is set to play a key role in determining the growth potential during 2016 to 2025 years. Analysts have also studied the molecular diagnostics industry to understand potential threats and challenges the molecular diagnostics industry companies could face. Although the molecular diagnostics industry is poised to grow at a fast pace across application, end user, product, and technique segments, factors such as the strictness of regulations associated with the approval process could slow down the molecular diagnostics market's growth worldwide.

Major Key Players:

Some of the Molecular Diagnostics Market Players are

Hoffmann-La Roche Ltd

Hologic, Inc.

QIAGEN

Becton, Dickinson and Company

Abbott Laboratories

Cepheid

Siemens

Thermo Fisher Scientific

Agilent Technologies

Segment Analysis

The molecular diagnostics market has been segmented into application, end user, product, and technique. Based on the segment which is application, the market is categorized on the basis of infectious diseases, genetic tests, cancer molecular diagnostics and others. The global market for molecular diagnostics is further segmented based on end user into diagnostic laboratories, hospitals & clinics, and others. Furthermore, the market, on the basis of product is segmented into instruments, reagents & kits, and services & software. Based on the segment which is technique, the market is categorized on the basis of hybridization, isothermal amplification, microarray, polymerase chain reaction (PCR), sequencing, and others. 

The global Market covers all the aspects of the molecular diagnostics market based on the segmental analysis of these application, end user, product, and technique segments. Analysts have also studied the global molecular diagnostics industry regional markets spread across many continents and countries. The application, end user, product, and technique segments along with their sub-segments have been analyzed and companies functioning in the molecular diagnostics industry across these segments are profiled and analyzed based on input and feedback from molecular diagnostics market based decision makers as well as primary and secondary sources. The Global Market presents analysis based information for companies functioning in the molecular diagnostics market.

Regional Analysis

Inaccurate results provided by faulty diagnostic kits may hinder the molecular diagnostics market growth. The market research report suggests that companies in the molecular diagnostics industry could be supported by advances in molecular diagnostics as well as molecular diagnostic technological advances during the forecast period. The molecular diagnostics is set to register growth at a high CAGR owing to these key factors. The molecular diagnostics is spread across North America, Europe, Asia-Pacific, and other parts of the world. The global Market reveals that APAC, North America, and Europe regional molecular diagnostics will dominate the global market for molecular diagnostics during the forecast period 2016 to 2025. As per Global Market, the market is set to witness tremendous growth across PCR, infectious disease testing, and advanced diagnostic laboratories segments in North America which covers molecular diagnostics markets across the United States, Canada, Mexico and several other regional markets. Companies active in the molecular diagnostics market are also analyzed and studied in the Global Market.

The molecular diagnostics for Europe covers smaller market segments of Germany, Italy, France, and the United Kingdom. Additionally, the Global Market covers the Asia-Pacific region covering molecular diagnostics markets from India, China, Japan, Australia, and others. The market is also spread across the rest of the world. The market report covers all such regions including the Middle East, Africa, Brazil, and others.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Artificial Heart Market Players, Growth, Size, Value Share, Industry Segment and Forecast to 2030

Artificial Heart Market

An artificial heart is a prosthetic device that is implanted into the body to provide circulation and replace heart ventricles that are diseased or damaged

Artificial Heart Market is expected to grow USD 4.98 billion at a CAGR 15.80% during the forecast period.

Segment Analysis

The global artificial heart market has been segmented into type, and end user.

By type, the market has been segmented into the heart-lung machine and mechanical heart. The mechanical heart is further segmented into total artificial hearts and ventricular assist devices (VADs). The mechanical heart segment is expected to register the highest CAGR during the forecast period due to growing demand.

On the basis of end user, the market has been segmented into Hospitals & Clinics, Specialty Centers, and others.

Major Key Players:

Some of the prominent players in the global artificial Artificial Heart Market Players are SynCardia Systems, LLC, BiVACOR Inc., CARMAT, Cleveland Heart, Inc., ABIOMED, CryoLife, Inc., Abbott, and Thoratec Corporation.

Regional Analysis

On a regional basis, the Americas is anticipated to dominate the global artificial heart market owing to the owing to increasing geriatric population, high prevalence of various chronic diseases, and a large number of diagnostic imaging centers.

Additionally, rising demand for advanced treatment and growing healthcare expenditure is driving the growth of the market. For instance, according to the American College of Cardiology Foundation, coronary heart disease (CHD) is the leading cause of deaths attributable to CV in the US. CHD contributes to over 43.8% of death cases in the US. Additionally, in 2015, the total healthcare expenditure for CVD and stroke in the US was an estimated USD 329.7 billion. CVD and stroke accounted for 14% of total health expenditures in 2015.

Europe accounts for the second largest market and holds a healthy share in the global artificial heart market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, and flourishing medical device industry due to the presence of major market players.

Asia-Pacific is expected to be the fastest growing market, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, and availability of favorable insurance policies.

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access, and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia is the largest market share owing to the development of the healthcare industry and the rising availability of specialty care centers.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Medical Billing Outsourcing Market Players, Opportunities, Trends and Forecast to 2030

Medical Billing Outsourcing Market

The medical billing outsourcing market is expected to reach USD 29.3 billion by 2030 at 11.2% CAGR during the forecast period 20220-2030

Major Growth Boosters and Challenges

Medical billing software and solutions help healthcare billers as well as coders offer efficient administrative services to customers and file claims that provide a host of benefits including reduced errors, accurate bills, lower insurance settlement rates, faster payment, digitalization, and invoice monitoring. Surge in technical innovations along with rise in M&A activities present lucrative opportunities to the medical billing software market.

The medical billing software industry is growing backed by the growing needs of health insurance firms, in terms of medical office management. The heightened preference for cloud-based medical billing software in clinics and hospitals is the latest trend witnessed in the global market.  The market is inundated with numerous players that are involved in fierce competition. Global firms are working on expanding their presence in emerging countries, which will be a huge challenge for local companies, as the competition will rise in terms of features like quality, pricing, and product differentiation. The global market witnesses established vendors indulging in competitive strategies such as collaboration, acquisition, expansion, product launch and partnership, to improve their standing.

Furthermore, surging requirement for risk and compliance management combined with the mounting prevalence of digitalization in the healthcare sector should accelerate the market growth in the next few years. Rapidly expanding patient population owing to various disorders and infections also foster the growth of the medical billing market. 

Major Key Players:

Some of the Medical Billing Outsourcing Market Players are R1 RCM Inc., Allscripts, Cerner Corporation, EClinical Works, Experian Information Solutions Inc., GENERAL ELECTRIC COMPANY, Genpact, HCL Technologies Limited, Kareo, Inc., McKesson Corporation, Quest Diagnostics Incorporated, The SSI Groups Inc, and others.

Regional Analysis

The Americas dominated the global market for medical billing industry analysis owing to the increasing healthcare expenditure, the presence of major market players, and rising adoption of medical billing outsourcing software by the hospitals within the region. It was found that around 80% of hospitals considering outsourcing full revenue cycle management by 2019. Moreover, in 2018, AdvancedMD announced the availability of ePayments, which facilitates to collect outstanding patient balances and reduce aging A/R more quickly and conveniently.

In 2017, it was estimated that Europe stood second in the global Medical Billing Outsourcing Market. This can be attributed to the increasing need to make billing processes efficient.

Asia-Pacific was the fastest growing region in 2017. Emerging economies, such as Singapore, Australia, India, and China, are the most lucrative markets due to the increasing patient pool and improving healthcare facilities. The increasing awareness about medical billing software and their growing importance coupled with the supportive government programs and policies are going to boost up the market.

On the other hand, the Middle East and Africa held the least share in the global Medical Billing Outsourcing Market due to the lack of healthcare awareness, and lack of advanced technology. However, Saudi Arabia and the UAE lead in terms of market shares in this region because of a good economy, skilled medical professionals, and accessibility to modern technology thus, contributing to the steady growth of the market in the Middle Eastern and African region.

Segmentation

The global Medical Billing Outsourcing Market is segmented based on product, material type, application, end user, and region.

The global market for medical billing outsourcing, by component, is segmented into outsourced and in-house. The outsourced segment is anticipated to hold the largest market share owing to the rising adoption of medical billing software by hospitals. 

Based on service, the market is segmented into front end, middle, and back end. The front-end services, usually, includes preregistration, registration, eligibility, scheduling, pre-authorization, etc. Due to the market saturation, front-end services segment is facing decline.

Based on end user, the market is segmented into hospitals, physician’s office, and others. The hospitals segment is expected to hold the largest market share due to rising cases of diseases.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Atherectomy Devices Market Demand, Growth, Top Key Players and Forecast to 2030

Atherectomy Devices Market

Atherectomy devices are widely used to treat peripheral arterial disease and coronary disease. Every device is designed differently to vaporize, sand, shave, or cut plaques, resting on their characteristics. Rotational atherectomy systems, photo-ablative atherectomy systems, orbital atherectomy systems, and directional atherectomy systems are the four most widely used atherectomy devices. 

The atherectomy devices market is expected to reach USD 681.43 Million by 2030 at 11.9% CAGR during the forecast period 2022-2030.

Numerous factors are adding to the global atherectomy devices market. Such factors, according to the recent MRFR report, include strengthening distribution channels of leading product manufacturers, burgeoning demand for atherectomy procedures that are minimally invasive, favorable medical reimbursements, commercialization, and continuous product development, and rising target patient population. Additional factors adding to the global atherectomy devices market growth include increasing investments by government organizations, untapped market opportunities, especially in emerging countries, rising prevalence of various neurovascular and cardiovascular diseases (peripheral artery disease), and growing healthcare expenditure.

On the contrary, scarcity of skilled medical professionals and post-operative complications are factors that may limit the global atherectomy devices market growth over the forecast period. 

Major Key Players:

Notable Atherectomy Devices Market Players include Cardinal Health, Straub Medical, Koninklijke Philips, B. Braun Melsungen AG, Boston Scientific Corporation, Minnetronix, Inc., Avinger, Biotronik, Abbott, C.R. Bard, Biomerics, and others. Industry players have adopted strategies such as strategic alliances, extensive research, and development activities, joint ventures, collaborations, and new product launches to stay ahead in the competition. 

Segment Analysis

The Market Research Future Report provides an inclusive segmental analysis of the global atherectomy devices market based on application, product type, and end user. 

By product type, the atherectomy devices market is segmented into rotational atherectomy systems, photo-ablative atherectomy systems, orbital atherectomy systems, directional atherectomy systems, and others. Rotational atherectomy systems allow percutaneous coronary intervention, especially for calcified coronary lesions that are complex. It functions on the differential cutting principle and preferentially ablates inelastic, hard, calcified plaque. The photo-ablative atherectomy systems help in vaporizing the plaque. The orbital atherectomy system helps to continuously clear plaque by pulverizing into small particles. The directional atherectomy system helps to remove the plaque by cutting through one direction. Of these, directional atherectomy systems will lead the market over the forecast period.

By application, the global atherectomy devices market is segmented into peripheral vascular, neurovascular, cardiovascular, and others. Of these, the peripheral vascular segment will dominate the market over the forecast period. 

By end user, the global atherectomy devices market is segmented into ambulatory surgery centers, hospitals, and others. Of these, hospitals is likely to have a major share in the market over the forecast period. 

Regional Analysis

The Americas holds the dominant share in the global atherectomy devices market, followed by Europe. The growing prevalence of atherosclerosis in North America is likely to ensure continued dominance of the Americas in the global atherectomy devices market over the forecast period.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Proteomics Market Players, Synopsis, Surge, Future Scope, Analysis and Forecast to 2030

Proteomics Market

Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis.

The Global Proteomics Market is anticipated to hold a market value of USD 67.5 billion in 2030 and is expected to grow at a CAGR of 12.3% during the forecast period.

Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation proteomics workflows.  However, reduced funding in key markets of proteomics, high cost of tools & equipment and lack of skilled researchers can restrain the market growth over the assessment period.

Major Key Players:

Some of the prominent Proteomics Market Players are GENERAL ELECTRIC COMPANY, Bio-Rad Laboratories, Inc., Danaher, Siemens Ltd., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Genzyme Corporation, Biognosys AG, Bruker, Luminex Corporation, Merck KGaA, PerkinElmer Inc., WATERS, Caprion Biosciences Inc. and Others.

Segment Analysis

The global proteomics market, as per the discussion of MRFR analysts, has been studied on the basis of equipment, service, and application. This study holds details regarding factors and revenues that will facilitate strategy-devising procedures. 

By equipment, the global market for proteomics has been segmented into mass spectroscopy, protein microarray, chromatography, protein fractionation, x-ray crystallography, and others. The protein fractionation is getting traction for its rising demand in the research process encompassing COVID-19.

By services, the global market report will cover segments like laboratory services and data analysis & services. The largest market share is getting enjoyed by the laboratory services segment as it has a significant contribution to finding effective diagnosis and research for drug discovery. The data analysis and services segment will register the fastest CAGR during the forecast period for its rising demand in the data analytics sector.

By application, the global report on the proteomics market has been segmented into clinical diagnosis, drug discovery, and others. The drug discovery segment is witnessing demand as several pharmaceutical companies have started procedures to find a proper drug and vaccine for COVID-19.

Regional Analysis

Geographically, the Americas is expected to dominate the global market owing to the easy availability of funds from various organizations and rising interest in personalized medicines. According to the Personalized Medicine Coalition, number of available personalized medicines increased to 113 in 2014 from 13 in 2006. Europe is expected to hold the second largest position in the global market owing to the rising cancer research activities and high funding from the government. Asia-Pacific is expected to be the fastest growing market owing to the high prevalence of cancer and rising healthcare expenditure. Moreover, the Middle East and Africa region is expected to account for the least market share in the global market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Huntington’s Disease Treatment Market 2022 Global Industry - Key Players, Size, Share, Trends, Opportunities, Growth Analysis and Forecast to 2030

 

Huntington’s Disease Treatment Market

Huntington Disease is a brain disorder that causes uncontrolled movements, emotional problems, and loss of thinking ability. Huntington disease usually appears in a person at a age of 30 or 40. Early symptoms can include irritability, depression, small involuntary movements, poor coordination, and trouble learning new information or making decisions. The individuals suffering from this disorder may have trouble in walking, speaking, and swallowing. People with this disorder also experience decline in thinking and reasoning abilities. Individuals suffering with this huntington disease usually live about 15 to 20 years after signs and symptoms begin.

Huntington’s Disease Treatment Market is expected to reach USD 373.31 Million rise steadily at a CAGR of 19.1% during forecast period of 2022-2030.

Huntington’s disease treatment market is expected to grow in the near future due to rise in incidence of genetic diseases, increasing research and development activities to develop drugs that can be used for treatment of this disorder and developing healthcare sector. Key players in market are making their position in many developing countries due to the FDI policies regulated within the pharmaceuticals industry in such countries with increasing consumer demands towards maintaining aesthetic appearance is also driving the market for global huntington’s disease treatment market.

However, some factors that can hamper the growth of this market are rising side effect associated with drugs, lack of awareness regarding genetic disorder and alternative treatment plan.   

Major Key Players:

Some of the Huntington’s Disease Treatment Market Players are engaged in new launches of drug and devices so as to maintain the strategic collaborations to hold its market position

Some of the key players in the global huntington’s disease treatment market are AmpliPhi Biosciences Corp, Ceregene Inc., Lundbeck, Prana Biotechnology Limited, Cortex Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Auspex Pharmaceuticals, SOM Biotech, GlaxoSmithKline, Siena Biotech, Raptor Pharmaceutical, Pfizer, Palobiofarma, Omeros Ipsen, Valeant Pharmaceuticals International Inc., Alnylam Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd.

Regional Analysis

America is expected to hold the highest market share for huntington market treatment  and the reason being many market players are engaged in development of new drug product innovation. Whereas increasing awareness of genetic disorders and rising healthcare expenditure by the government and rise in incidence of these genetic disease are some of the factors responsible for growth of market in this region    

Europe is expected to be the second largest market in the globe owing to the increasing aging population, increasing prevalence of huntington’s disease, focus on aesthetic appearance, increasing research base. Whereas rise in susceptible immune compromised patient population is responsible for market growth in this region. 

Asia-Pacific is anticipated to be the fastest growing market owing to the changing lifestyle, increase in population, increasing healthcare expenditure by government are some of the factor responsible for market growth in this region. 

Middle East and Africa is expected to account for the smallest share in the global huntington’s disease treatment market due to underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Segment Analysis

Global huntington’s disease treatment market is segmented into drug type, treatment and end-users. On basis of drug type the global huntington disease treatment market is segmented into tetrabenazine, deutetrabenazine, selective serotonin reuptake inhibitor (SSRI), chlorpromazine,haloperidol, risperidone, olanzapine, clozapine another drug type.

Based on treatment the market is further segmented into two types such as symptomatic therapy and disease-modifying therapy.On basis of end-users the market is further segmented into hospital, clinics, retail pharmacies, online pharmacies and others.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Medical Radiation Detection, Monitoring & Safety Market Players, Demand, Opportunities, Trends and Forecast to 2027

Medical Radiation Detection, Monitoring & Safety Market

increasing prevalence of cancer diseases and increasing number of diagnostic imaging centers are expected to drive the growth of market. According to American Cancer Society, Inc., in 2017, about 1,688,780 new cancer cases diagnosed in US. On other hand, the lack of skilled radiation professionals can restrain the market growth over the assessment period.

The global medical radiation detection, monitoring & safety market anticipated to have held a market value of USD 961 million in the year 2017 and is expected to grow at a CAGR of 7.1% during the forecast period. Radiation Detection, Monitoring & Safety products provides safety environment in healthcare settings.

The growing prevalence of cancer has led to growing use of radioactive materials for the treatment of cancer. Radiotherapy has emerged as one of the most promising treatment avenues for cancer, leading to growing use of radioactive substances in the oncology sector. This is likely to remain one of the most important drivers for the global medical radiation detection, monitoring, and safety market over the forecast period, as cancer has become a major problem for the healthcare sector in modern times and is likely to remain one of the key challenges facing the healthcare sector in the coming years.

Increasing awareness about radiation safety among workers is also likely to be a major driver for the global medical radiation detection, monitoring, and safety market over the forecast period. While the use of radioactive materials in the healthcare sector is nothing new, the handling and treatment of the substances has changed completely compared to earlier, as government regulations and workplace safety regulations have taken it into account and formulated specific rules regarding the use of nuclear materials in the healthcare sector. The growing concern about the threat posed by radioactive materials is likely to be a major driver for the global medical radiation detection, monitoring, and safety market over the forecast period.

Major Key Players:

Some of the Medical Radiation Detection, Monitoring & Safety Market Players are Mirion Technologies, Inc., Thermo Fisher Scientific Inc., Sun Nuclear Corporation, IBA Worldwide, Radiation Detection Company Inc., Biodex Medical Systems, Inc., Ludlum Measurements, Inc., Amray Medical, Infab Corporation, and Fluke Biomedical.

Segment Analysis

The global medical radiation detection, monitoring & safety market has been segmented into detector type, monitoring type, safety type, and end user.

Based on detector type, market is segmented into gas-filled detectors, organic scintillators, inorganic scintillators and solid-state detectors. The gas-filled detectors segment is expected to account for the largest share and fastest growing segment of the global market in 2017.

Based on monitoring type, medical radiation detection, monitoring and safety market is segmented into Personal Dosimeters, Environmental monitors, Area Monitors, Radiological material Monitors, Others.

Based on safety type, medical radiation detection, medication and safety market segmented into Full-Body Protection Products, Face Protection Products, and others.

Based on end user, the market segmented into hospitals, clinics, ambulatory surgical centers, and others.

Regional Analysis

Regionally, the global medical radiation detection, monitoring, and safety market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas dominates the global medical radiation detection, monitoring, and safety market and is likely to remain by far the most important regional market over the forecast period due to the growing prevalence of cancer and the increasing expenditure on R&D of advanced radioactivity protection solutions.

Many major players in the medical radiation detection, monitoring, and safety market are located in North America, giving the region an advantage in terms of adopting the latest technological advances and incorporating them into the day to day functioning of the healthcare sector. Europe is also likely to be a major player in the global medical radiation detection, monitoring, and safety market for this very reason.

Asia Pacific is likely to exhibit rapid growth in the medical radiation detection, monitoring, and safety market over the forecast period due to the growing demand for cancer treatment in countries such as China, India, and Australia.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com